Logo image of MEG

MONTROSE ENVIRONMENTAL GROUP (MEG) Stock Fundamental Analysis

NYSE:MEG - New York Stock Exchange, Inc. - US6151111019 - Common Stock - Currency: USD

14.44  +0.35 (+2.48%)

After market: 14.44 0 (0%)

Fundamental Rating

3

Taking everything into account, MEG scores 3 out of 10 in our fundamental rating. MEG was compared to 83 industry peers in the Commercial Services & Supplies industry. MEG has a bad profitability rating. Also its financial health evaluation is rather negative. MEG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MEG has reported negative net income.
MEG had a positive operating cash flow in the past year.
MEG had negative earnings in each of the past 5 years.
MEG had a positive operating cash flow in each of the past 5 years.
MEG Yearly Net Income VS EBIT VS OCF VS FCFMEG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

MEG has a Return On Assets of -7.41%. This is in the lower half of the industry: MEG underperforms 75.90% of its industry peers.
MEG's Return On Equity of -13.61% is on the low side compared to the rest of the industry. MEG is outperformed by 62.65% of its industry peers.
Industry RankSector Rank
ROA -7.41%
ROE -13.61%
ROIC N/A
ROA(3y)-6.43%
ROA(5y)-8.4%
ROE(3y)-11.31%
ROE(5y)-15.93%
ROIC(3y)N/A
ROIC(5y)N/A
MEG Yearly ROA, ROE, ROICMEG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

With a decent Gross Margin value of 39.95%, MEG is doing good in the industry, outperforming 66.27% of the companies in the same industry.
In the last couple of years the Gross Margin of MEG has grown nicely.
The Profit Margin and Operating Margin are not available for MEG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.16%
GM growth 5Y5.98%
MEG Yearly Profit, Operating, Gross MarginsMEG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

MEG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MEG has more shares outstanding
Compared to 5 years ago, MEG has more shares outstanding
MEG has a worse debt/assets ratio than last year.
MEG Yearly Shares OutstandingMEG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MEG Yearly Total Debt VS Total AssetsMEG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MEG has an Altman-Z score of 0.98. This is a bad value and indicates that MEG is not financially healthy and even has some risk of bankruptcy.
MEG has a worse Altman-Z score (0.98) than 72.29% of its industry peers.
MEG has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.40, MEG is in line with its industry, outperforming 55.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACCN/A
WACC8.06%
MEG Yearly LT Debt VS Equity VS FCFMEG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

MEG has a Current Ratio of 1.50. This is a normal value and indicates that MEG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MEG (1.50) is comparable to the rest of the industry.
MEG has a Quick Ratio of 1.48. This is a normal value and indicates that MEG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.48, MEG is in line with its industry, outperforming 57.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.48
MEG Yearly Current Assets VS Current LiabilitesMEG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MEG have decreased strongly by -39.87% in the last year.
MEG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.58%.
MEG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.38% yearly.
EPS 1Y (TTM)-39.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)11.58%
Revenue growth 3Y8.42%
Revenue growth 5Y24.38%
Sales Q2Q%14.07%

3.2 Future

Based on estimates for the next years, MEG will show a very strong growth in Earnings Per Share. The EPS will grow by 27.32% on average per year.
MEG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.01% yearly.
EPS Next Y62.75%
EPS Next 2Y37.82%
EPS Next 3Y27.32%
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2Y7.79%
Revenue Next 3Y12.56%
Revenue Next 5Y13.01%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MEG Yearly Revenue VS EstimatesMEG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
MEG Yearly EPS VS EstimatesMEG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MEG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MEG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEG Price Earnings VS Forward Price EarningsMEG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MEG is valued a bit more expensive than the industry average as 66.27% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.8
MEG Per share dataMEG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as MEG's earnings are expected to grow with 27.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.82%
EPS Next 3Y27.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MEG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTROSE ENVIRONMENTAL GROUP

NYSE:MEG (4/22/2025, 8:19:33 PM)

After market: 14.44 0 (0%)

14.44

+0.35 (+2.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-13 2025-05-13
Inst Owners100.91%
Inst Owner Change-0.02%
Ins Owners7%
Ins Owner Change0.68%
Market Cap500.49M
Analysts78
Price Target32.53 (125.28%)
Short Float %10.28%
Short Ratio6.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-15.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-192.55%
Min EPS beat(2)-313.73%
Max EPS beat(2)-71.36%
EPS beat(4)0
Avg EPS beat(4)-119.31%
Min EPS beat(4)-313.73%
Max EPS beat(4)-16.61%
EPS beat(8)1
Avg EPS beat(8)-74.15%
EPS beat(12)2
Avg EPS beat(12)-71.48%
EPS beat(16)4
Avg EPS beat(16)-155.78%
Revenue beat(2)0
Avg Revenue beat(2)-2.4%
Min Revenue beat(2)-4.61%
Max Revenue beat(2)-0.2%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)1.07%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)5
Avg Revenue beat(12)-0.82%
Revenue beat(16)9
Avg Revenue beat(16)4.31%
PT rev (1m)-3.55%
PT rev (3m)-8.3%
EPS NQ rev (1m)-11.07%
EPS NQ rev (3m)-21.25%
EPS NY rev (1m)-75.27%
EPS NY rev (3m)-9688.24%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-2.67%
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF N/A
P/OCF 22.51
P/B 0.93
P/tB N/A
EV/EBITDA 29.8
EPS(TTM)-2.21
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.64
OCFY4.44%
SpS20.09
BVpS15.56
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.41%
ROE -13.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.95%
FCFM N/A
ROA(3y)-6.43%
ROA(5y)-8.4%
ROE(3y)-11.31%
ROE(5y)-15.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.16%
GM growth 5Y5.98%
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 8.87
Cap/Depr 45.17%
Cap/Sales 3.42%
Interest Coverage N/A
Cash Conversion 91.22%
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.48
Altman-Z 0.98
F-Score3
WACC8.06%
ROIC/WACCN/A
Cap/Depr(3y)46.06%
Cap/Depr(5y)35.19%
Cap/Sales(3y)3.51%
Cap/Sales(5y)2.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y62.75%
EPS Next 2Y37.82%
EPS Next 3Y27.32%
EPS Next 5YN/A
Revenue 1Y (TTM)11.58%
Revenue growth 3Y8.42%
Revenue growth 5Y24.38%
Sales Q2Q%14.07%
Revenue Next Year8.07%
Revenue Next 2Y7.79%
Revenue Next 3Y12.56%
Revenue Next 5Y13.01%
EBIT growth 1Y-28.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year847.86%
EBIT Next 3Y135.77%
EBIT Next 5Y76.48%
FCF growth 1Y-106.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.31%
OCF growth 3Y-16.05%
OCF growth 5Y5.47%